A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine
Abstract Background The large volume of medical literature makes it difficult for healthcare professionals to keep abreast of the latest studies that support Evidence-Based Medicine. Natural language processing enhances the access to relevant information, and gold standard corpora are required to im...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Medical Informatics and Decision Making |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12911-021-01395-z |
id |
doaj-23ec51d897d64bcd879152e951fea49c |
---|---|
record_format |
Article |
spelling |
doaj-23ec51d897d64bcd879152e951fea49c2021-02-23T09:18:04ZengBMCBMC Medical Informatics and Decision Making1472-69472021-02-0121111910.1186/s12911-021-01395-zA clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicineLeonardo Campillos-Llanos0Ana Valverde-Mateos1Adrián Capllonch-Carrión2Antonio Moreno-Sandoval3Computational Linguistics Laboratory, Universidad Autónoma de MadridMedical Terminology Unit, Spanish Royal Academy of Medicine.Complejo Asistencial Hospital Benito Menni.Computational Linguistics Laboratory, Universidad Autónoma de MadridAbstract Background The large volume of medical literature makes it difficult for healthcare professionals to keep abreast of the latest studies that support Evidence-Based Medicine. Natural language processing enhances the access to relevant information, and gold standard corpora are required to improve systems. To contribute with a new dataset for this domain, we collected the Clinical Trials for Evidence-Based Medicine in Spanish (CT-EBM-SP) corpus. Methods We annotated 1200 texts about clinical trials with entities from the Unified Medical Language System semantic groups: anatomy (ANAT), pharmacological and chemical substances (CHEM), pathologies (DISO), and lab tests, diagnostic or therapeutic procedures (PROC). We doubly annotated 10% of the corpus and measured inter-annotator agreement (IAA) using F-measure. As use case, we run medical entity recognition experiments with neural network models. Results This resource contains 500 abstracts of journal articles about clinical trials and 700 announcements of trial protocols (292 173 tokens). We annotated 46 699 entities (13.98% are nested entities). Regarding IAA agreement, we obtained an average F-measure of 85.65% (±4.79, strict match) and 93.94% (±3.31, relaxed match). In the use case experiments, we achieved recognition results ranging from 80.28% (±00.99) to 86.74% (±00.19) of average F-measure. Conclusions Our results show that this resource is adequate for experiments with state-of-the-art approaches to biomedical named entity recognition. It is freely distributed at: http://www.lllf.uam.es/ESP/nlpmedterm_en.html . The methods are generalizable to other languages with similar available sources.https://doi.org/10.1186/s12911-021-01395-zClinical TrialsEvidence-Based MedicineSemantic AnnotationInter-Annotator AgreementNatural Language Processing |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leonardo Campillos-Llanos Ana Valverde-Mateos Adrián Capllonch-Carrión Antonio Moreno-Sandoval |
spellingShingle |
Leonardo Campillos-Llanos Ana Valverde-Mateos Adrián Capllonch-Carrión Antonio Moreno-Sandoval A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine BMC Medical Informatics and Decision Making Clinical Trials Evidence-Based Medicine Semantic Annotation Inter-Annotator Agreement Natural Language Processing |
author_facet |
Leonardo Campillos-Llanos Ana Valverde-Mateos Adrián Capllonch-Carrión Antonio Moreno-Sandoval |
author_sort |
Leonardo Campillos-Llanos |
title |
A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine |
title_short |
A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine |
title_full |
A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine |
title_fullStr |
A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine |
title_full_unstemmed |
A clinical trials corpus annotated with UMLS entities to enhance the access to evidence-based medicine |
title_sort |
clinical trials corpus annotated with umls entities to enhance the access to evidence-based medicine |
publisher |
BMC |
series |
BMC Medical Informatics and Decision Making |
issn |
1472-6947 |
publishDate |
2021-02-01 |
description |
Abstract Background The large volume of medical literature makes it difficult for healthcare professionals to keep abreast of the latest studies that support Evidence-Based Medicine. Natural language processing enhances the access to relevant information, and gold standard corpora are required to improve systems. To contribute with a new dataset for this domain, we collected the Clinical Trials for Evidence-Based Medicine in Spanish (CT-EBM-SP) corpus. Methods We annotated 1200 texts about clinical trials with entities from the Unified Medical Language System semantic groups: anatomy (ANAT), pharmacological and chemical substances (CHEM), pathologies (DISO), and lab tests, diagnostic or therapeutic procedures (PROC). We doubly annotated 10% of the corpus and measured inter-annotator agreement (IAA) using F-measure. As use case, we run medical entity recognition experiments with neural network models. Results This resource contains 500 abstracts of journal articles about clinical trials and 700 announcements of trial protocols (292 173 tokens). We annotated 46 699 entities (13.98% are nested entities). Regarding IAA agreement, we obtained an average F-measure of 85.65% (±4.79, strict match) and 93.94% (±3.31, relaxed match). In the use case experiments, we achieved recognition results ranging from 80.28% (±00.99) to 86.74% (±00.19) of average F-measure. Conclusions Our results show that this resource is adequate for experiments with state-of-the-art approaches to biomedical named entity recognition. It is freely distributed at: http://www.lllf.uam.es/ESP/nlpmedterm_en.html . The methods are generalizable to other languages with similar available sources. |
topic |
Clinical Trials Evidence-Based Medicine Semantic Annotation Inter-Annotator Agreement Natural Language Processing |
url |
https://doi.org/10.1186/s12911-021-01395-z |
work_keys_str_mv |
AT leonardocampillosllanos aclinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT anavalverdemateos aclinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT adriancapllonchcarrion aclinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT antoniomorenosandoval aclinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT leonardocampillosllanos clinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT anavalverdemateos clinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT adriancapllonchcarrion clinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine AT antoniomorenosandoval clinicaltrialscorpusannotatedwithumlsentitiestoenhancetheaccesstoevidencebasedmedicine |
_version_ |
1724254858037428224 |